AMZN
Amazon.com, Inc.
AMZN has the edge over LEGH overall, supported by stronger modeled upside and stronger valuation.
LEGH
Legacy Housing Corporation
LEGH offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
LEGH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
LEGH's revenue, profitability, cash flow and balance sheet are all currently strong.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over LEGH in the historical PE scenario, which offers more potential upside but is not a forecast.
LEGH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $21.99 | -23% |
| Fair | 11x | $28.70 | +1.1% |
| Current | 11x | $28.38 | — |
| Expensive | 13x | $33.71 | +19% |
| Forward | 14x | $28.38 | — |
Historical ranges are pointers, not guarantees.
LEGH's PE is in its fair range at 11x. Analysts expect earnings to fall, which would put today's price at 14x next year's earnings, in its expensive range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over LEGH on the outlook, with more favorable earnings and revenue expectations.
LEGH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect LEGH's earnings and revenue to decline, with profitability weakening.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over LEGH on earnings, with more consistent year-over-year improvement.
LEGH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.07 | -23% |
| Q3 2026 | $2.68 | +37% |
| Q2 2026 | $2.18 | -2.7% |
| Q1 2026 | $1.79 | -22% |
| Q4 2025 | $1.74 | -30% |
| Q3 2025 | $1.95 | -10% |
| Q2 2025 | $2.24 | +3.2% |
| Q1 2025 | $2.29 | +8% |
| Q4 2024 | $2.48 | +14% |
LEGH earned $2.68 per share over the past year, up 37% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over LEGH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
LEGH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.7M | +72% |
| Q2 2026 | $66.3M | +32% |
| Q1 2026 | $34.4M | -3.7% |
| Q4 2025 | $38.3M | -29% |
| Q3 2025 | $40.5M | -8.6% |
| Q2 2025 | $50.2M | +18% |
| Q1 2025 | $35.7M | -18% |
| Q4 2024 | $54.2M | +61% |
LEGH's revenue is growing: $70M last quarter, up 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +9.6 points |
| Q2 2026 | 40% | +6.4 points |
| Q1 2026 | 36% | +3.5 points |
| Q4 2025 | 27% | -1.7 points |
| Q3 2025 | 24% | -11 points |
| Q2 2025 | 34% | -4.2 points |
| Q1 2025 | 33% | -6.2 points |
| Q4 2024 | 29% | -0.2 points |
LEGH has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
LEGH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.4M | +45% |
| Q2 2026 | $12.3M | +235% |
| Q1 2026 | $5.4M | +49% |
| Q4 2025 | $15.7M | +161% |
| Q3 2025 | $5.1M | -44% |
| Q2 2025 | $3.7M | +114% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | $6M | +$17.4M |
LEGH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
LEGH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -29.6K shares |
| 1 year | -2.7% | -649K shares |
| 3 years | -5.3% | -1.3M shares |
| 5 years | -2.1% | -499K shares |
| Available history | -2.7% | -653K shares |
LEGH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $93,000 |
| Q1 2026 | $573,000 |
| Q4 2025 | $1.1M |
| Q3 2025 | $1,000 |
| Q2 2025 | $5.8M |
| Q1 2025 | $675,000 |
| Q4 2024 | — |
LEGH spent $2M buying back its own shares over the past year, down 73% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LEGH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q3 2024 | 0.0x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.2x | Very low |
LEGH has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
LEGH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 35.9 | Neutral |
LEGH's weekly RSI is 58 (neutral) and its Stochastic is 36 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
LEGH PE vs Consumer Cyclical Sector
| Metric | LEGH | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 41% below |
| PE % | 47 | 47 | Same percentile |
LEGH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over LEGH on trend strength, trading above more of its moving averages.
LEGH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.6 | 0.8% below |
| 20 week MA | $28.0 | 1.2% above |
| 50 week MA | $24.2 | 17% above |
| 100 week MA | $24.2 | 17% above |
| 200 week MA | $23.6 | 20% above |
LEGH's trend is up, with a small recent dip: it's below only its 8-week average, and 20% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
LEGH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $14.9 | -11% |
| 2021 | $14.9 | $25.8 | +74% |
| 2022 | $25.8 | $17.8 | -31% |
| 2023 | $17.8 | $25.2 | +41% |
| 2024 | $25.2 | $24.8 | -1.7% |
| 2025 | $24.8 | $19.8 | -20% |
| 2026 YTD | $19.8 | $28.4 | +43% |
LEGH has the edge over AMZN on returns for 2026, with the stronger performance.